BergaMet NA Introduces ‘Clinical IMMUNE’ to Combat Upper Respiratory Symptoms
Natural supplement formulated exclusively with Citrus Bergamot SuperFruit™ and BetaVia™ Complete Las Vegas – Oct. 13, 2020 – BergaMet NA, a subsidiary of Grey Cloak Technologies (OTC: GRCK – Pending name change to Healthy Extracts Inc.), introduces BergaMet Clinical...
Grey Cloak Tech Inc. Launches Customer Relationship Management (CRM) Program to Increase Sales and Retention
LAS VEGAS – Oct. 8, 2020 – via NetworkWire – Grey Cloak Tech Inc. (OTC: GRCK – soon to be Healthy Extracts Inc. pending a corporate name change), a company engaged in proprietary development of natural plant-based formulations as well as sales and distribution of...
Grey Cloak Tech Inc. Introduces ‘Clinical IMMUNE™’ to Combat Respiratory Symptoms.
LAS VEGAS – Oct.6, 2020 – via NetworkWire – Grey Cloak Tech Inc. (OTC: GRCK – name change pending to Healthy Extracts Inc.), today announces that its BergaMet NA subsidiary has introduced BergaMet Clinical IMMUNE™, a concentrated nutraceutical supplement formulated...
Grey Cloak Tech Inc. Announces Q2 Filing, Reports First-Half 2020 Earnings and Corporate Update
Filing and six-month results underscore GRCK’s commitment to advancing corporate strategies to build shareholder value and expand line of proprietary offerings LAS VEGAS, September 15th, 2020 -- via NetworkWire -- Grey Cloak Tech Inc. (OTC: GRCK) (the “Company”),...
Grey Cloak Tech Inc. Files for Name Change to Healthy Extracts Inc.
LAS VEGAS (Sept.__, 2020) -- via NetworkWire -- Grey Cloak Tech Inc., (OTC: GRCK) (the “Company”), today announces it has filed a Schedule 14C to notify shareholders of a name change to Healthy Extracts Inc. as part of the Company’s corporate strategy that aligns...
General form for quarterly reports under Section 13 or 15(d) – Form 10-Q
For further details see: General form for quarterly reports under Section 13 or 15(d) - Form 10-Q News Provided by SEC Filings via QuoteMedia
Annual report pursuant to Section 13 or 15(d) – Form 10-K
For further details see: Annual report pursuant to Section 13 or 15(d) - Form 10-K News Provided by SEC Filings via QuoteMedia
General form for quarterly reports under Section 13 or 15(d) – Form 10-Q
For further details see: General form for quarterly reports under Section 13 or 15(d) - Form 10-Q News Provided by SEC Filings via QuoteMedia
General form for quarterly reports under Section 13 or 15(d) – Form 10-Q
For further details see: General form for quarterly reports under Section 13 or 15(d) - Form 10-Q News Provided by SEC Filings via QuoteMedia
General form for quarterly reports under Section 13 or 15(d) – Form 10-Q
For further details see: General form for quarterly reports under Section 13 or 15(d) - Form 10-Q News Provided by SEC Filings via QuoteMedia
NetworkNewsBreaks – Grey Cloak Tech Inc. (GRCK) Introduces Proprietary Ketogenic Solution for Brain Health – F4T(TM)
Grey Cloak Tech (OTC: GRCK), engaged in proprietary development of natural plant-based formulations, sales and distribution of cardiovascular and neuro products, on Thursday introduced its proprietary F4T(TM) formulation, a natural ketogenic solution clinically proven...
Grey Cloak Tech Inc. Introduces F4T(TM) Proprietary Formulation for Brain Health
Results from major clinical study of F4T™ will be presented at Annual Conference of the American College of Sports Medicine Las Vegas, NV -(NewMediaWire) - May 14, 2020 - Grey Cloak Tech Inc. (OTC: GRCK) (the “Company”), engaged in proprietary development of natural...